Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey - PubMed (original) (raw)
Comparative Study
. 1986 Sep 8;251(2):260-80.
doi: 10.1002/cne.902510209.
- PMID: 3782501
- DOI: 10.1002/cne.902510209
Comparative Study
Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey
B J Balin et al. J Comp Neurol. 1986.
Abstract
Pathways traversed by peripherally administered protein tracers for entry to the mammalian brain were investigated by light and electron microscopy. Native horseradish peroxidase (HRP) and wheat germ agglutinin (WGA) conjugated to peroxidase were administered intranasally, intravenously, or intraventricularly to mice; native HRP was delivered intranasally or intravenously to rats and squirrel monkeys. Unlike WGA-HRP, native HRP administered intranasally passed freely through intercellular junctions of the olfactory epithelia to reach the olfactory bulbs of the CNS extracellularly within 45-90 minutes in all species. The olfactory epithelium labeled with intravenously delivered HRP, which readily escaped vasculature supplying this epithelium. Blood-borne peroxidase also exited fenestrated vessels of the dura mater and circumventricular organs. This HRP in the mouse, but not in the other species, passed from the dura mater through patent intercellular junctions within the arachnoid mater; in time, peroxidase reaction product in the mouse brain was associated with the pial surface, the Virchow-Robin spaces of vessels penetrating the pial surface, perivascular clefts, and with phagocytic pericytes located on the abluminal surface of superficial and deep cerebral microvasculature. Blood-borne HRP was endocytosed avidly at the luminal face of the cerebral endothelium in all species. WGA-HRP and native HRP delivered intraventricularly to the mouse were not endocytosed appreciably at the abluminal surface of the endothelium; hence, the endocytosis of protein and internalization of cell surface membrane within the cerebral endothelium are vectorial. The low to non-existent endocytic activity and internalization of membrane from the abluminal endothelial surface suggests that vesicular transport through the cerebral endothelium from blood to brain and from brain to blood does not occur. The extracellular pathways through which probe molecules enter the mammalian brain offer potential routes of passage for blood-borne and air-borne toxic, carcinogenic, infectious, and neurotoxic agents and addictive drugs, and for the delivery of chemotherapeutic agents to combat CNS infections and deficiency states. Methodological considerations are discussed for the interpretation of data derived from application of peroxidase to study the blood-brain barrier.
Similar articles
- Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system.
Broadwell RD, Sofroniew MV. Broadwell RD, et al. Exp Neurol. 1993 Apr;120(2):245-63. doi: 10.1006/exnr.1993.1059. Exp Neurol. 1993. PMID: 8491281 - Endocytic and exocytic pathways of the neuronal secretory process and trans-synaptic transfer of wheat germ agglutinin-horseradish peroxidase in vivo.
Broadwell RD, Balin BJ. Broadwell RD, et al. J Comp Neurol. 1985 Dec 22;242(4):632-50. doi: 10.1002/cne.902420410. J Comp Neurol. 1985. PMID: 2418083 - Pathways into, through, and around the fluid-brain barriers.
Broadwell RD. Broadwell RD. NIDA Res Monogr. 1992;120:230-58. NIDA Res Monogr. 1992. PMID: 1501688 Review. - Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal.
Broadwell RD. Broadwell RD. Acta Neuropathol. 1989;79(2):117-28. doi: 10.1007/BF00294368. Acta Neuropathol. 1989. PMID: 2688350 Review.
Cited by
- Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs.
Lofts A, Abu-Hijleh F, Rigg N, Mishra RK, Hoare T. Lofts A, et al. CNS Drugs. 2022 Jul;36(7):739-770. doi: 10.1007/s40263-022-00930-4. Epub 2022 Jun 27. CNS Drugs. 2022. PMID: 35759210 Free PMC article. Review. - Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain.
Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J, Zhang L, Steinman L, Miller D, Zhang HG. Zhuang X, et al. Mol Ther. 2011 Oct;19(10):1769-79. doi: 10.1038/mt.2011.164. Epub 2011 Sep 13. Mol Ther. 2011. PMID: 21915101 Free PMC article. - FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review.
Fieux M, Le Quellec S, Bartier S, Coste A, Louis B, Giroudon C, Nourredine M, Bequignon E. Fieux M, et al. Int J Mol Sci. 2021 Jun 17;22(12):6475. doi: 10.3390/ijms22126475. Int J Mol Sci. 2021. PMID: 34204226 Free PMC article. - The contribution of the meningeal immune interface to neuroinflammation in traumatic brain injury.
Mokbel AY, Burns MP, Main BS. Mokbel AY, et al. J Neuroinflammation. 2024 May 27;21(1):135. doi: 10.1186/s12974-024-03122-7. J Neuroinflammation. 2024. PMID: 38802931 Free PMC article. Review. - New advances in CNS immunity against viral infection.
Manglani M, McGavern DB. Manglani M, et al. Curr Opin Virol. 2018 Feb;28:116-126. doi: 10.1016/j.coviro.2017.12.003. Epub 2017 Dec 29. Curr Opin Virol. 2018. PMID: 29289900 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources